Key Stats for P&G Stock
- Current Price: $143.50
- Target Price (Mid): ~$201
- Street Target: ~$164
- Potential Total Return: ~37%
- Annualized IRR: ~8% / year
- Earnings Reaction: +0.15% (April 24, 2026)
- Max Drawdown: 18.75% (January 7, 2026)
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
Procter & Gamble (PG) stock is down about 16% from its 52-week high, yet the business just delivered its first volume growth in over a year. The stock barely moved on earnings day, closing up just 0.15% on April 24 despite beating both revenue and EPS estimates. Bulls argue the volume recovery is structural and the selloff has created a rare entry point into a Dividend King. Bears point to a $1 billion after-tax oil cost headwind heading into fiscal 2027. The real question is whether P&G’s pricing power and innovation engine are strong enough to absorb that pressure. CFO Andre Schulten’s remarks on the April 24 earnings call, reviewed against P&G’s investor relations materials, offer a more direct answer than the headline numbers do.
What the Q3 Numbers Actually Showed
Q3 FY2026 organic sales grew more than 3%, with volume up 2 points and pricing contributing 1 point, per the earnings release. All 10 product categories and all 7 geographic regions grew organic sales. Net sales came in at $21.235 billion, beating the analyst consensus of $20.504 billion by 3.57%, per TIKR’s Beats & Misses data. Core EPS was $1.59 versus the $1.56 estimate.
Regionally, North America’s organic sales grew 4%, Latin America’s grew 5%, Greater China’s grew 3%, and Europe’s enterprise markets grew 6%. Skin and Personal Care was the strongest segment, growing in high single digits. Hair Care, Family Care, and Home Care each grew mid-single digits.
One important clarification: while all 10 categories grew organic sales (which includes pricing and mix), the SEC 8-K filing noted that Grooming and Health Care each saw volume declines within those results. Volume growth was broad, but not universal across every segment.
See historical and forward estimates for P&G stock (It’s free!) >>>
What the CFO Said That Actually Moves the Thesis
The earnings call transcript is where the real investment case lives. Schulten gave three specific examples that go beyond the headline beat.
On Tide, he described a formula upgrade he called “the biggest upgrade we made in 25 years,” launched at the same price point, which drove “mid-teens growth” on one of P&G’s largest U.S. businesses. On SK-II in China, he cited 18% total growth and 13% growth in China proper, inside a market he described as one where “growth is still negative across most channels.” On Germany Pantene, a shift toward social and influencer media tripled total reach with 20% less media spend, lifting Pantene value share by 60 basis points.
These examples answer the central bear argument directly. The concern heading into 2026 was that cumulative price increases had permanently eroded P&G’s ability to take further pricing. Schulten addressed it plainly: “I don’t think we’ve lost pricing power. I think pricing power has to be earned, and the way to earn pricing power is to combine pricing with truly a delightful experience for the consumer.”
That is a specific operating model, innovation first and selective pricing attached to it, backed by measurable results at Tide, SK-II, and Pantene.
The one gap Schulten named himself: Baby Care in the U.S. P&G is not growing domestic Baby Care share. He said so plainly, noted investment and a new plan are in place, but it remains a watch item heading into Q4.
The $1 Billion Headwind in Context
The cost picture is real. Schulten quantified it on the call: if Brent crude holds near $100 per barrel, the annual impact is roughly $1.3 billion before tax ($1 billion after tax) versus a pre-conflict price in the mid-$60s. That covers feedstock, logistics rerouting from the Middle East conflict, and higher diesel costs. Full-year FY2026 guidance was maintained at 0% to 4% organic sales growth and core EPS of $6.83 to $7.09, but results are now expected toward the lower end of that range.
What tempers the concern is P&G’s track record. The company navigated the post-COVID supply chain crisis using the same levers Schulten described on this call: rapid reformulation, supply diversification, and productivity pulls within the P&L. The two-year restructuring program now underway targets a 15% reduction in non-manufacturing headcount, with pre-tax costs of $1.5 billion to $2 billion that are funding savings not yet in the earnings run rate.
TIKR’s forward estimates show consensus revenue reaching around $87.1 billion in FY2026 and around $89.5 billion in FY2027, a two-year compound annual growth rate of roughly 3.1% from FY2025’s $84.3 billion. Free cash flow on a trailing twelve-month basis is $12.7 billion, supporting the planned $15 billion in shareholder returns for FY2026 ($10 billion in dividends and $5 billion in buybacks, per the earnings call).
On valuation, PG trades at an NTM EV/EBITDA of 15.33x, per TIKR’s Multiples data. Kimberly-Clark (KMB) trades at 10.36x and Church & Dwight (CHD) at 16.33x, with the household products peer group median at 8.19x, per TIKR’s Competitors page. P&G trades at nearly twice the category median, a premium that has historically been supported by its 51.0% LTM gross margin. Whether the commodity environment compresses that multiple is the live valuation debate.
The 70th consecutive annual dividend increase, announced in April 2026, puts the current yield at 3.0% per TIKR, giving income investors a reason to hold through the near-term cost pressure.
See how P&G performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $143.50
- Target Price (Mid): ~$201
- Potential Total Return: ~37%
- Annualized IRR: ~8% / year
See analysts’ growth forecasts and price targets for P&G stock (It’s free!) >>>
The mid-case uses around 3.6% revenue CAGR through FY2030. The two primary growth drivers are the organic volume recovery now visible in North America (4% organic sales, volume up 3 points in Q3) and continued enterprise market expansion across Latin America, Asia Pacific, and Africa, where Q3 delivered 4% to 6% organic growth. The margin driver is the restructuring program’s savings, which Schulten confirmed on the call are being scaled across categories through automation and supply chain digitization.
The low case at around 3.2% revenue growth still projects around $205 by mid-2030 per TIKR’s model. The high case at around 3.9% growth and around 20.5% net income margins projects around $299. The primary risk across all scenarios is oil staying above $100 per barrel through FY2027, which would narrow the productivity offset and likely push core EPS growth toward flat for the year.
Conclusion
Watch fiscal Q4 earnings, expected in late July 2026. The metric to track is organic sales growth. Schulten guided Q4 organic sales to come in somewhat below Q3’s 3%-plus level, partly because a roughly 1-point trade inventory pull-forward from Q4 into Q3 around Easter timing will reverse. If Q4 organic sales hold above 2%, the moderation is explainable, and the volume recovery narrative stays intact. If it falls materially below that, the FY2027 headwind narrative takes over.
One-sentence thesis: P&G’s Q3 results confirm the innovation playbook is working, volume is recovering, and the commodity headwind is the kind of disruption this company has absorbed before without breaking its long-term compounding story.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in P&G?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up P&G, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track P&G alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
